Preferred Label : adenosine;

MeSH definition : A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.;

MeSH hyponym : adenocard; Adenoscan;

MeSH CAS label : adenosine;

MeSH Related Number : 58-61-7 (Adenosine);

Registry Number MeSH : 58-61-7;

MeSH annotation : /biosyn /physiol permitted;

Wikipedia link : https://en.wikipedia.org/wiki/Adenosine;

Codes EINECS : 200-389-9;

Is substance : O;

UNII : K72T3FS567;

InChIKey : OIRDTQYFTABQOQ-KQYNXXCUSA-N;

Details


Main resources

You can consult :

A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.

https://www.has-sante.fr/portail/jcms/c_2860514/fr/adenosine-accord
2018
false
false
false
false
France
French
evaluation of the transparency committee
adenosine
adenosine

---
https://www.has-sante.fr/portail/jcms/c_2847928/fr/brilique
2018
false
false
false
false
France
French
evaluation of the transparency committee
Brilique
adenosine
Ticagrelor

---
http://sfar.org/wp-content/uploads/2018/03/2_Gestion-des-agents-antiplaquettaires-pour-une-procedure-invasive-programmee.pdf
https://doi.org/10.1016/j.anrea.2018.01.002
2018
false
false
false
France
French
platelet aggregation inhibitors
hemorrhage
postoperative complications
platelet aggregation inhibitors
embolism and thrombosis
aspirin
administration, oral
Prasugrel Hydrochloride
risk management
risk assessment
continuity of patient care
patient safety
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
platelet aggregation inhibitors excl. heparin
surgical procedures, operative
blood loss, surgical
perioperative period
ticlopidine
ticlopidine
adenosine
adenosine
Clopidogrel
Ticagrelor

---
https://www.has-sante.fr/portail/jcms/c_2800626/fr/brilique
2017
false
false
false
false
France
French
evaluation of the transparency committee
Brilique
adenosine
Ticagrelor

---
https://www.revmed.ch/RMS/2016/RMS-N-520/Double-antiagregation-plaquettaire-pour-le-traitement-et-la-prevention-secondaire-de-la-maladie-coronarienne-Indications-modalites-et-durees-de-traitement
2017
false
false
false
Switzerland
French
journal article
secondary prevention
platelet aggregation inhibitors
coronary disease
coronary disease
Duration of treatment (qualifier value)
hemorrhage
platelet aggregation inhibitors
review of literature
drug therapy, combination
aspirin
administration, oral
treatment outcome
Prasugrel Hydrochloride
ischemia
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
purinergic P2Y12 receptor antagonists
purinergic P2Y12 receptor antagonists
percutaneous coronary intervention
acute coronary syndrome
practice guidelines as topic
ticlopidine
ticlopidine
adenosine
adenosine
Clopidogrel
Ticagrelor

---
http://www.has-sante.fr/portail/jcms/c_2587886/fr/adenosine-medac
2016
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
injections, intravenous
adenosine
adult
child
adolescent
anti-arrhythmia agents
adenosine
tachycardia
tachycardia
treatment outcome
wolff-parkinson-white syndrome
Chemical Cardioversion
adenosine

---
http://www.has-sante.fr/portail/jcms/c_2619966/fr/adenosine-panpharma
2016
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Adenosine 3mg/mL injection solution 2mL vial (product)
Adenosine 3mg/mL infusion solution 10mL vial (product)
adenosine
adenosine

---
http://www.cochrane.org/fr/CD009503
2013
United Kingdom
France
French
meta-analysis
treatment outcome
adenosine
verapamil
myocardial infarction
acute disease
percutaneous coronary intervention
acute myocardial infarction, nos
french abstract

---
https://www.ema.europa.eu/medicines/human/EPAR/Possia
2012
United Kingdom
French
syndication feed
drug approval
treatment outcome
drug interactions
pregnancy
adenosine
administration, oral
atherosclerosis
thrombosis
ticagrelor
drug therapy, combination
platelet aggregation inhibitors
platelet aggregation inhibitors
adult
myocardial infarction
angina, unstable
stroke
myocardial infarction
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
drug evaluation
summary of product characteristics
package leaflet
Ticagrelor
Ticagrelor

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/brilinta-1420.html
2012
false
Canada
English
French
CORONARY STENT, OTHER
evaluation of the transparency committee
acute coronary syndrome
administration, oral
treatment outcome
Cost-Benefit analysis
purinergic P2Y receptor antagonists
adenosine
ticagrelor
platelet aggregation inhibitors
drug therapy, combination
thrombosis
atherosclerosis
clinical trials as topic
aspirin
drug evaluation
Ticagrelor

---
Summary Basis of Decision (SBD) for BRILINTA - Ticagrelor, 90 mg tablet
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00021
2011
false
Canada
French
English
CORONARY STENT, OTHER
administration, oral
drug approval
treatment outcome
risk assessment
ticagrelor
adenosine
drug therapy, combination
aspirin
platelet aggregation inhibitors
platelet aggregation inhibitors
acute coronary syndrome
thrombosis
atherosclerosis
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
clinical trials as topic
drug evaluation
Ticagrelor
Ticagrelor

---
http://www.has-sante.fr/portail/jcms/c_1172422/brilique
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-01/brilique_07-12-2011_avis_ct10968.pdf
2011
France
French
evaluation of the transparency committee
administration, oral
ticagrelor
insurance, health, reimbursement
clinical trials as topic
platelet aggregation inhibitors
platelet aggregation inhibitors
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
adenosine
adult
drug therapy, combination
acute coronary syndrome
myocardial infarction
atherosclerosis
thrombosis
multicenter studies as topic
comparative study
Ticagrelor
Ticagrelor

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60710318
2010
false
France
French
diagnostic uses of chemicals
Chemical Cardioversion
adenosine
adenosine
adenosine
anti-arrhythmia agents
anti-arrhythmia agents
tachycardia
tachycardia
adenosine
injections, intravenous
drug interactions
pregnancy
breast feeding
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61855583
2010
France
French
diagnostic uses of chemicals
adenosine
infusions, intravenous
adenosine
adenosine
vasodilator agents
vasodilator agents
myocardial perfusion imaging
adult
aged
drug interactions
pregnancy
breast feeding
coronary vessels
summary of product characteristics
package leaflet

---
Nous contacter.
20/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.